Side effects found in patient studies
Tesamorelin side effects and who must avoid it
Studies found sore shot spots, joint stiffness, and mild swelling. Doctors also watch IGF-1, a liver-made growth protein, during care.
What side effects to watch for with tesamorelin
Researchers made tesamorelin for excess belly fat. Safety trials tracked each side effect. The most common problems began where the shot entered skin. Growth hormone and IGF-1 also caused known effects [5]. IGF-1 is a liver-made growth protein. These effects included aching joints and mild fluid buildup.
Blood sugar stayed steady during testing. Doctors included patients with type 2 diabetes [7]. The shots didn't cause dangerous sugar spikes. The drug label rules out tesamorelin in three cases [7]. Those are active cancer, drug allergy, and pregnancy. Doctors also follow growth-related blood tests.
Most side effects were mild and eased during treatment.
What symptoms tesamorelin caused during treatment
Patient trials found two main groups of side effects.
Skin came first. Daily shots entered beneath belly skin. Some patients saw mild redness or felt itching. Others had light swelling around the needle spot.
The next group followed higher growth hormone and IGF-1. IGF-1 is a liver-made growth protein. Patients sometimes reported aching joints or stiff muscles. Fluid also gathered in some hands and ankles. These effects came with the intended hormone rise.
The studies were limited, but most findings were reassuring. A diabetes study reported mainly mild symptoms and no dangerous reactions [7]. Patients also handled the early study well [8]. In 2026, a review joined five trials and found no severe medical problems [3]. Federal liver experts checked tesamorelin too [5]. They found no known case of liver injury from the drug. Liver blood tests stayed normal in the trials.
Call your doctor if a symptom worries you. The studies can't tell how your body will respond.
What blood sugar checks found during tesamorelin studies
Doctors ran a safety study in patients with diabetes [7]. Daily shots of 1 or 2 mg didn't raise fasting blood sugar. The three-month sugar average stayed steady. Insulin levels stayed steady too. Harmful cholesterol improved with 2 mg each day. No volunteer had a serious medical problem. Another study followed 13 healthy men [4]. Their bodies handled sugar the same after 2 mg daily. An early dose study also recorded steady sugar readings [8].
During the 52-week trials, doctors saw no worrying sugar change [2].
In these studies, "safe" meant no liver harm or sharp sugar rise. It didn't mean that checks were no longer needed. Patients with diabetes still need routine blood tests.
Your doctor can compare those tests over time. One reading may not show the longer trend.
What IGF-1 cancer warning doctors follow with tesamorelin
Tesamorelin raises natural growth hormone. It also raises IGF-1, a liver-made protein involved when cells grow. Doctors therefore watch IGF-1 and tumor risks with care.
Trials followed treated patients for 52 weeks [2]. Cancer cases didn't rise during that time. Still, growth signals may feed a tumor that already exists. Active cancer therefore rules the drug out [7]. Cancer care must be over. The cancer must be inactive before a doctor may consider the shots.
No new cancer sign appeared in the trials. That doesn't erase the active-cancer rule. Your doctor needs your full cancer history.
Who must avoid tesamorelin under the drug rules
The drug rules out tesamorelin in three medical cases.
First, anyone with active cancer must avoid it. Cancer care must be finished, and the cancer must be inactive. Second, anyone allergic to tesamorelin must avoid it [7]. The warning includes mannitol, a type of sugar that keeps the vial powder stable. Third, pregnant women must not use the shots. Animal studies found severe birth defects in developing young. The main trials included women and men, but pregnancy is still ruled out.
Did tesamorelin raise blood sugar in diabetes studies?
Doctors tested adults with type 2 diabetes taking 1 or 2 mg daily [7]. The shots didn't raise fasting blood sugar. Longer-term sugar averages and insulin stayed steady. Unhealthy cholesterol fell with the 2 mg amount. Healthy men also handled sugar normally [4]. An early dose trial found no sugar spikes [8]. Doctors still check blood sugar during care.
Did tesamorelin cause fluid buildup and swelling?
Fluid buildup and stiff joints can appear when growth hormone rises. IGF-1, a liver-made growth protein, rises during care too. These reactions were mostly mild in patient studies. The diabetes study found minor symptoms without serious problems [7]. Earlier dose studies also found that patients handled treatment well [8].
What did tesamorelin studies find in women?
The main trials included both women and men. Belly-fat loss and side effects were similar [1]. Safety was also similar in women who weren't pregnant. Pregnancy remains ruled out because animal studies found severe birth defects [7]. These are the official safety rules.